Charles River Laboratories — Third Quarter 2026 Earnings Summary

Charles River Laboratories reported third-quarter 2026 revenue of $982.7 million, reflecting a 2.2% decline from the prior year primarily due to divestitures, while organic revenue grew 4.7%. The company achieved a non-GAAP operating margin of 23.0% and non-GAAP earnings per share of $3.09, representing a 27.2% year-over-year increase. Driven by strong performance in the Discovery and Safety Assessment segment and a lower effective tax rate, Charles River raised its full-year 2026 guidance for both revenue and non-GAAP earnings per share.